Ralliant Corporation (NYSE:RAL - Get Free Report) CEO Tamara Newcombe sold 12,936 shares of Ralliant stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the completion of the sale, the chief executive officer directly owned 251,967 shares in the company, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ralliant Stock Down 3.5%
NYSE:RAL traded down $2.54 during trading hours on Tuesday, reaching $69.42. 1,336,205 shares of the stock were exchanged, compared to its average volume of 1,694,804. The stock has a market cap of $7.68 billion, a PE ratio of -6.40, a PEG ratio of 2.69 and a beta of 1.61. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $75.41. The firm has a 50 day moving average of $68.82 and a 200 day moving average of $55.58. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00.
Ralliant (NYSE:RAL - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.05. The company had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, equities analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current year.
Ralliant Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant's payout ratio is presently -1.84%.
Hedge Funds Weigh In On Ralliant
Institutional investors have recently bought and sold shares of the business. Danske Bank A S bought a new position in shares of Ralliant during the 4th quarter worth approximately $25,000. Dunhill Financial LLC bought a new stake in Ralliant in the 2nd quarter valued at $25,000. Allworth Financial LP lifted its holdings in Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company's stock valued at $26,000 after purchasing an additional 293 shares during the last quarter. Palisade Asset Management LLC acquired a new stake in Ralliant during the 3rd quarter valued at $26,000. Finally, BOKF NA bought a new position in Ralliant during the third quarter worth $29,000.
Analyst Ratings Changes
RAL has been the topic of several analyst reports. Royal Bank Of Canada upped their target price on Ralliant from $71.00 to $73.00 and gave the stock a "sector perform" rating in a report on Friday, July 31st. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Ralliant in a research report on Friday, July 31st. TD Cowen upped their price objective on Ralliant from $70.00 to $80.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Wall Street Zen downgraded Ralliant from a "strong-buy" rating to a "buy" rating in a report on Tuesday, August 11th. Finally, Truist Financial reissued a "buy" rating and issued a $82.00 target price (up from $68.00) on shares of Ralliant in a research note on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $75.70.
Check Out Our Latest Research Report on Ralliant
About Ralliant
(
Get Free Report)
Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Ralliant, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ralliant wasn't on the list.
While Ralliant currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
